Pcv115 - Quality of Inr Control and Switching to Doac Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study.

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.660
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Quality of INR Control and Switching to Non-Vitamin K Oral Anticoagulants Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study

PLoS ONE
Multidisciplinary
2019English

Pcv19 - Patterns of Anticoagulation Control and Clinical Outcomes in Atrial Fibrillation Patients Treated With Vitamin K Antagonists: A Real-World Study Using Population-Based Data and Group-Based Trajectory Models

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Patient Characteristics and Bleeding Events in Nonvalvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists: Real-World Evidence From Italian Administrative Databases

Journal of Comparative Effectiveness Research
Health Policy
2018English

Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease

Research and Practice in Thrombosis and Haemostasis
2019English

Analysis of Warfarin Usage and INR Control in Atrial Fibrillation: A Retrospective Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

Patients’ Knowledge and Perspectives on Vitamin K Antagonists for Stroke Prevention in Atrial Fibrillation: Implications for Treatment Quality

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy